Recent studies found that ACC tumours could be categorized into two main subtypes, in which ACC-I exhibited MYC overexpression and NOTCH mutation with poor prognosis, and ACC-II exhibited P63 overexpression and RTK upregulation with improved prognosis [6, 61]. This evidence concerns the gene MYC and adrenal cortex carcinoma.